drugset / Trial / NCT04409665

The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST)

NCT04409665

Phase 1 Unknown 60 enrolled Medical University of Warsaw
RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the efficacy and impact of intravenous ketamine or sublingual 30% glucose as sedation drugs used in preterm premature babies during the LISA procedure. The second goal is to compare the frequency of complications during LISA with both premedication regimens.

Timeline

Start
2020-01-01
Primary completion
2022-03-31
Completion
2022-04-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glucose Unknown 1 ml Other
Comparator Glucose Unknown 30 % Other
Subject Ketamine Small molecule 1 mg/kg Intravenous